Live birth · women with subfertility
It is very uncertain whether antioxidant(s) changes live birth; antioxidants vs placebo or no treatment/standard… compared with placebo or no treatment/standard treatment (very low certainty).
1 finding from 1 review
Clinical pregnancy · women with subfertility
Antioxidant(s) may leads to higher clinical pregnancy; antioxidants vs placebo or no treatment/standard… compared with placebo or no treatment/standard treatment (low certainty).
1 finding from 1 review
Dill seed versus placebo Pain score · women with moderate or severe primary dysmenorrhoea
11 findings from 1 review
Show 8 more findings
Relief of pain · women with moderate or severe primary dysmenorrhoea
Dietary supplements may leads to higher zataria versus placebo Pain relief compared with placebo (low certainty).
3 findings from 1 review
Zinc sulphate versus placebo Adverse effects · women with moderate or severe primary dysmenorrhoea
It is very uncertain whether dietary supplements changes zinc sulphate versus placebo Adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Ginger versus placebo Adverse effects · women with moderate or severe primary dysmenorrhoea
It is very uncertain whether dietary supplements changes ginger versus placebo Adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Improvement in pain score (up to nine months after treatment): progesterone versus placebo · women with chronic pelvic pain
Medical treatment probably leads to higher improvement in pain score at end of treatment: progesterone versus… compared with placebo (moderate certainty).
2 findings from 1 review
Weight gain · women with chronic pelvic pain
Medical treatment leads to higher weight gain: progesterone versus placebo compared with placebo (high certainty).
1 finding from 1 review
Bloatedness: progesterone versus placebo · women with chronic pelvic pain
Medical treatment leads to higher bloatedness: progesterone versus placebo compared with placebo (high certainty).
1 finding from 1 review
Peto OR 3.2 [1.37, 7.47]
85 participants
High
Improvement in pain score: lofexidine versus placebo · women with chronic pelvic pain
Medical treatment showed no clear difference in improvement in pain score: lofexidine versus placebo compared with placebo (low certainty).
1 finding from 1 review
Drowsiness/lethargy: lofexidine versus placebo · women with chronic pelvic pain
Medical treatment probably leads to higher drowsiness/lethargy: lofexidine versus placebo compared with placebo (moderate certainty).
1 finding from 1 review
Dry mouth (xerostomia) · women with chronic pelvic pain
Medical treatment probably leads to higher dry mouth: lofexidine versus placebo compared with placebo (moderate certainty).
1 finding from 1 review
Clinical pregnancyMetformin plus liraglutide vs metformin Met + CC + L‐carnitine vs Met + CC + placebo · obese women with subfertility
It is very uncertain whether pharmacological intervention changes clinical pregnancyMetformin plus liraglutide vs metformin Met + CC +… compared with pharmacological intervention (very low certainty).
1 finding from 1 review
MiscarriageMet + CC + L‐carnitine vs Met + CC + placebo · obese women with subfertility
It is very uncertain whether pharmacological intervention changes miscarriageMet + CC + L‐carnitine vs Met + CC + placebo compared with pharmacological intervention (very low certainty).
1 finding from 1 review
Weight ‐ BMI changeMetformin plus liraglutide vs metformin Met + CC + L‐carnitine vs Met + CC + placebo Weight changeDexfenfluramine vs placebo Weight ‐ body fatMetformin plus liraglutide vs metformin · obese women with subfertility
1 finding from 1 review
Improvement in symptoms (clinician‐assessed) (oestrogen tablets vs placebo) · postmenopausal women with vaginal atrophy
Oestrogen tablets may leads to higher improvement in symptoms (clinician‐assessed) (oestrogen tablets vs… compared with other regimens (low certainty).
1 finding from 1 review
Adverse events (total adverse events) (oestrogen cream vs non‐hormonal lubricant gel) · postmenopausal women with vaginal atrophy
Oestrogen tablets showed no clear difference in adverse events (total adverse events) (oestrogen tablets vs placebo) compared with other regimens (moderate certainty).
1 finding from 1 review
Improvement in symptoms (participant‐assessed) oestrogen cream vs placebo) · postmenopausal women with vaginal atrophy
Oestrogen cream may leads to higher improvement in symptoms (participant‐assessed) oestrogen cream vs… compared with other regimens (low certainty).
1 finding from 1 review
Improvement in symptoms (clinician‐assessed) (oestrogen cream vs placebo) · postmenopausal women with vaginal atrophy
Oestrogen cream may leads to higher improvement in symptoms (clinician‐assessed) (oestrogen cream vs… compared with other regimens (low certainty).
1 finding from 1 review
Adverse events (total adverse events) (oestrogen cream vs non‐hormonal lubricant gel) · postmenopausal women with vaginal atrophy
Oestrogen ring showed no clear difference in adverse events (total adverse events) (oestrogen ring vs placebo) compared with other regimens (moderate certainty).
1 finding from 1 review